is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
With two in three people overweight or obese in the Middle East, sometimes dieting is not enough. The Allurion Balloon is the world's first and only weight loss device that requires no surgery, endoscopy, or anaesthesia. Available across clinics in the United Arab Emirates, Allurion supports long-term weight loss through a revolutionary gastric balloon that creates a feeling of fullness by taking up space in the stomach, providing patients with the chance to take a break from dieting and that all too familiar feeling of hunger.
With around 60,000 patients worldwide, Allurion is changing the approach to weight loss and the diseases attributed to it including, cardiovascular disease, cancer, diabetes and polycystic ovary syndrome to name but a few. It is more than "just a gastric balloon". It is a swallowable pill that expands in the stomach to around the size of a grapefruit. Requiring no surgical insertion, this world-first technology is placed during a brief 20-minute visit and passes naturally after approximately 16 weeks, allowing patients to lose an average of 10 to 15% within that time frame.
No weight loss programme is a magic bullet and an effective programme is based on good healthcare and good science. With this in mind, Allurion is a proven programme that takes a holistic approach to losing weight. At the centre of the programme is the revolutionary soft balloon and after the 16-week period patients benefit from six months of dietary support from a nutritionist to ensure lasting lifestyle changes alongside a body composition scale and Health Tracker linked to an app to follow progress.
Shantanu Gaur, co-founder and CEO at Allurion, said the mission is to help people realize their full potential with innovative, scalable, and trusted experience.
“At Allurion, we have developed what I call the “Weight Loss 2.0” experience. It is more effective than diet and exercise but safer, more affordable and easier than weight loss surgery,” Gaur said.
By combining a high-tech balloon solution with a full package of support to help its patients develop good lifestyle habits that can remain with them long after their balloon has gone, The Allurion Program results in more weight loss than diet or exercise alone. One clinical study with 509 patients showed that 95% of average weight loss with Allurion can be sustained at the 12 month follow up. Furthermore, in a study of 42 patients, the average weight loss with two sequential Allurion Balloons was 22.8% total body weight loss. The maximum weight loss achieved was 40.9% body weight loss in 12 months. A temporary balloon does not mean temporary weight loss.
For more information, please visit https://allurion.com/en/find-clinic